antibody-drug conjugates

South Korea's first-generation biopharma venture company CrystalGenomics Inc. on Wednesday said it received a $2 million (2.6 billion won) order fro...

South Korea is poised to boost the biotech industry by accelerating research, education and business partnerships with the biopharmaceutical sector ...

South Korean biosimilar giant Celltrion Inc. revealed on Wednesday the highly anticipated clinical phase 1 data for its Actemra biosimilar, CT-P47, ...

South Korea's HanAll Biopharma Co. and Daewoong Pharmaceutical on Thursday said they concluded a contract with NurrOn Pharmaceuticals of the US on...

South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has obtained product approval from the US Food and Drug Adminis...

South Korean bio-venture Cellid Co. announced on Tuesday that it has applied for the clinical Phase 3 trial of the COVID-19 Omicron variant-specific...

South Korea's CJ Bioscience Inc., a pharmaceutical company specializing in intestinal microorganisms called microbiomes, will conduct a paid-in capi...

HLB Co. announced on May 17 that it has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for the approval of Rivo...

South Korea’s Daewoong Pharmaceutical said on Friday that it had concluded three technology export agreements for new drugs and new drug candi...

South Korea's gene therapeutics developer Lemonex announced on Tuesday that it has signed a memorandum of understanding (MOU) with the World Health ...

South Korea’s SK Biopharmaceuticals said on Wednesday that the Israeli Ministry of Health has approved the company's new drug application (NDA...

LG Chem Ltd. is slated for exclusive talks with Seoul-based Glenwood Private Equity to sell off its in vitro diagnostics business, according to biop...

SK Bioscience Co., the drug-making unit of South Korea’s SK Group, plans to spend 2.4 trillion won ($1.8 billion) over the next five years and...

South Korean new drug developer Kainos Medicine Inc. announced on Friday that it had signed a technology transfer agreement with Chinese pharmaceuti...

South Korea’s biopharmaceutical company GeneOne Life Science Inc. on Tuesday said it received a patent from the China National Intellectual Pr...

South Korean drugmaker Daewoong Pharmaceutical Co. said on Tuesday that it has signed a cooperation agreement with Sygnature Discovery, a British ne...

South Korea's pharmaceutical companies are competing to sell generic drugs to raise their presence on the domestic market for diabetes treatment wit...

South Korean drug developer JW Pharmaceutical has entered into a memorandum of understanding (MOU) with Zefit, a domestic non-clinical trial institu...

South Korean chemical company LG Chem Ltd. has announced the release of a new diabetes combination drug, Zemidapa Tab, set to launch on Apr. 8. Th...

South Korea's the Ministry of Food and Drug Safety announced on Friday that it had revised the "Risk Management Plan (RMP) Guidelines" to allow for ...

Kolon Pharma, the pharmaceutical affiliate of South Korea's Kolon Group, is merging with anti-cancer drug developer Platbio to advance the developme...

South Korean biosimilar giant Celltrion Group aims to transform into a drug developer by generating 40% of sales from new medicines by 2030 as it is...

Biorchestra Co., a South Korean company specializing in RNA-based therapeutics, announced on Tuesday that it has entered into a joint research and o...

South Korea’s pharmaceutical and healthcare company CJ Bioscience Inc. has acquired drug candidates from the UK's 4D pharma plc. to improve co...

South Korean pharmaceutical company Kwangdong Pharmaceutical announced on Monday that it has signed a contract with Hong Kong-based Zhaoke Ophthalmo...

JW Pharmaceutical, a drug company based in South Korea, has received its first patent for a hair loss treatment that is currently in development. Th...

ST Pharm Co., a South Korean pharmaceutical firm, announced on Thursday that it had entered into an agreement to supply oligonucleotides to an undis...

South Korean biopharmaceutical firm Celltrion Inc. announced on Tuesday a joint research and development agreement with Genuv, Inc., a domestic drug...

Samsung Bioepis Co., a South Korean biosimilar firm, announced on Sunday that it has recently launched a new biosimilar drug called SB11 for the tre...

South Korea's GC Biopharma Corp. announced on Tuesday that it had entered into an agreement to transfer assets with Catalyst Biosciences, a US-based...